by The global In Vitro Fertilization market size is expected to be worth around US$ 43.9 billion by 2030, according to a new report by Vision Research Reports.
In Vitro Fertilization Market (By Type: Fresh Non-donor, Frozen Non-donor, Fresh Donor, Frozen Donor; By End-use: Fertility Clinics, Hospitals & Others Settings; By Instrument: Culture Media, Disposable Devices, Capital Equipment) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030
Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38313
Report Insight
| Report Coverage | Details |
| Market Size | US$ 43.9 billion by 2030 |
| Growth Rate | CAGR of 10.5% From 2021 to 2030 |
| Base year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Instrument, type, end-use, region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
| Companies Mentioned | OvaScience; EMD Serono Inc.; Vitrolife AB; Irvine Scientific; Cook Medical Inc.; Cooper Surgical Inc.; Genea Biomedx; Thermo Fisher Scientific Inc.; Progyny, Inc.; Boston IVF |
Report Highlights
The in vitro fertilization instrument consists of culture media, capital equipment, and IVF disposable devices. Culture media dominated the market in 2020 and accounted for a revenue share of more than 41%. This growth was credited to the factors, such as the availability of funding and an increase in research activities to improve the culture media. On the other hand, as industry players are introducing disposable devices, such as , slides, and chambers, to meet the sterility and regulatory requirements, the disposable devices segment is expected to likely grow at the fastest growth rate during the forecast years.
The frozen non-donor segment led the global market in 2020. The segment accounted for the maximum revenue share of more than 47% in 2020. The fresh non-donor segment accounted for the second-highest revenue share in 2020. The greater success rate in the first attempt is responsible for the high share of this segment, As the procedure can be performed even in complicated cases, the segment is also expected to witness the fastest CAGR from 2021 to 2030.
The fertility clinics segment dominated the global market accounting for the largest revenue share of more than 79% in 2020. The segment is likely to retain its dominant market position throughout the forecast period growing at the fastest CAGR from 2021 to 2030. With a rise in demand for ART treatments, the number of fertility clinics and ART centers is increasing considerably. Factors, such as cost-effectiveness, availability of specialists, and minimal or no chances of Hospital-Acquired Infections (HAIs), are anticipated to drive the growth of fertility clinics. IVF treatments are also performed in hospitals.
Europe dominated the global market with a revenue share of more than 37% in 2020. Factors, such as rising medical tourism and legal revisions related to IVF techniques, will propel the regional market growth during the forecast years.
Key Players
- OvaScience
- EMD Serono, Inc.
- Vitrolife AB
- Irvine Scientific
- Cook Medical, Inc.
- Cooper Surgical, Inc.
- Genea Biomedx
- Thermo Fisher Scientific, Inc.
- Progyny, Inc.
- Boston IVF
Market Segmentation
- Type Outlook
- Fresh Non-donor
- Frozen Non-donor
- Fresh Donor
- Frozen Donor
- End-use Outlook
- Fertility Clinics
- Hospitals & Others Settings
- Instrument Outlook
- Culture Media
- Disposable Devices
- Capital Equipment
- Regional Outlook
- North America
- U.S.
- Canada
- Europe
- France
- Germany
- Italy
- Spain
- U.K.
- Belgium
- The Netherlands
- Switzerland
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- Middle East & Africa (MEA)
- South Africa
- North America
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38313
The study objectives of this report are:
- To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
- Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- To define, describe and forecast the market by type, application and region.
- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
- To identify significant trends and factors driving or inhibiting the market growth.
- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
- To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global In Vitro Fertilization Market, By Type
7.1. In Vitro Fertilization Market, by Type, 2021-2030
7.1.1. Fresh Non-donor
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Frozen Non-donor
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Fresh Donor
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Frozen Donor
7.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global In Vitro Fertilization Market, By End-use
8.1. In Vitro Fertilization Market, by End-use, 2021-2030
8.1.1. Fertility Clinics
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Hospitals & Others Settings
8.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global In Vitro Fertilization Market, By Instrument
9.1. In Vitro Fertilization Market, by Instrument, 2021-2030
9.1.1. Culture Media
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Disposable Devices
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Capital Equipment
9.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global In Vitro Fertilization Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Type (2016-2030)
10.1.2. Market Revenue and Forecast, by End-use (2016-2030)
10.1.3. Market Revenue and Forecast, by Instrument (2016-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Type (2016-2030)
10.1.4.2. Market Revenue and Forecast, by End-use (2016-2030)
10.1.4.3. Market Revenue and Forecast, by Instrument (2016-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Type (2016-2030)
10.1.5.2. Market Revenue and Forecast, by End-use (2016-2030)
10.1.5.3. Market Revenue and Forecast, by Instrument (2016-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Type (2016-2030)
10.2.2. Market Revenue and Forecast, by End-use (2016-2030)
10.2.3. Market Revenue and Forecast, by Instrument (2016-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Type (2016-2030)
10.2.4.2. Market Revenue and Forecast, by End-use (2016-2030)
10.2.4.3. Market Revenue and Forecast, by Instrument (2016-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Type (2016-2030)
10.2.5.2. Market Revenue and Forecast, by End-use (2016-2030)
10.2.5.3. Market Revenue and Forecast, by Instrument (2016-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Type (2016-2030)
10.2.6.2. Market Revenue and Forecast, by End-use (2016-2030)
10.2.6.3. Market Revenue and Forecast, by Instrument (2016-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Type (2016-2030)
10.2.7.2. Market Revenue and Forecast, by End-use (2016-2030)
10.2.7.3. Market Revenue and Forecast, by Instrument (2016-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Type (2016-2030)
10.3.2. Market Revenue and Forecast, by End-use (2016-2030)
10.3.3. Market Revenue and Forecast, by Instrument (2016-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Type (2016-2030)
10.3.4.2. Market Revenue and Forecast, by End-use (2016-2030)
10.3.4.3. Market Revenue and Forecast, by Instrument (2016-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Type (2016-2030)
10.3.5.2. Market Revenue and Forecast, by End-use (2016-2030)
10.3.5.3. Market Revenue and Forecast, by Instrument (2016-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Type (2016-2030)
10.3.6.2. Market Revenue and Forecast, by End-use (2016-2030)
10.3.6.3. Market Revenue and Forecast, by Instrument (2016-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Type (2016-2030)
10.3.7.2. Market Revenue and Forecast, by End-use (2016-2030)
10.3.7.3. Market Revenue and Forecast, by Instrument (2016-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Type (2016-2030)
10.4.2. Market Revenue and Forecast, by End-use (2016-2030)
10.4.3. Market Revenue and Forecast, by Instrument (2016-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Type (2016-2030)
10.4.4.2. Market Revenue and Forecast, by End-use (2016-2030)
10.4.4.3. Market Revenue and Forecast, by Instrument (2016-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Type (2016-2030)
10.4.5.2. Market Revenue and Forecast, by End-use (2016-2030)
10.4.5.3. Market Revenue and Forecast, by Instrument (2016-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Type (2016-2030)
10.4.6.2. Market Revenue and Forecast, by End-use (2016-2030)
10.4.6.3. Market Revenue and Forecast, by Instrument (2016-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Type (2016-2030)
10.4.7.2. Market Revenue and Forecast, by End-use (2016-2030)
10.4.7.3. Market Revenue and Forecast, by Instrument (2016-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Type (2016-2030)
10.5.2. Market Revenue and Forecast, by End-use (2016-2030)
10.5.3. Market Revenue and Forecast, by Instrument (2016-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Type (2016-2030)
10.5.4.2. Market Revenue and Forecast, by End-use (2016-2030)
10.5.4.3. Market Revenue and Forecast, by Instrument (2016-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Type (2016-2030)
10.5.5.2. Market Revenue and Forecast, by End-use (2016-2030)
10.5.5.3. Market Revenue and Forecast, by Instrument (2016-2030)
Chapter 11. Company Profiles
11.1. OvaScience
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. EMD Serono, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Vitrolife AB
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Irvine Scientific
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Cook Medical, Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Cooper Surgical, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Genea Biomedx
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Thermo Fisher Scientific, Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Progyny, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Boston IVF
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38313
About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.
Contact Us:
call: +1 9197 992 333
Vision Research Report
Any Assistance, Email – sales@visionresearchreports.com
